GNBT Secures $3.6M Capital

Generex Biotechnology Corporation (OTCBB: GNBT) announced today that it has secured two commitments for an aggregate capital raise of CA$3,600,000. This funding is structured as term loans of one year from private lenders secured by the Company’s real estate. Interest on the loans is payable monthly at the rate of 10% per annum.

“This capital infusion will permit ...

Continue Reading →
25
JAN
0

Penny Stocks on the Move, Penny Stocks to Watch, Update

, , , , , , , , , , , , , , , , , , ,

$2.5 Billion Deal: Bristol-Meyers agrees to buy Inhibitex

 

Bristol-Myers Squibb Co. (NYSE: BMY) announced during morning trading in the stock market today that it will buy Alpharetta, Ga. based Inhibitex, Inc. (NASDAQ: INHX) for nearly $2.5 billion. Pending approval of the boards of directors of both companies, INHX is up over 140% today and over 500% since our first alert on INHX on Continue Reading →

9
JAN
0

Penny Stocks to Watch, Volume Alerts

, , , , , , ,